"An open-label extension study of the long-term safety,tolerability and efficacy of Ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension(CTEPH)."
2020-07-04
عنوان الدراسة
"An open-label extension study of the long-term safety,tolerability and efficacy of Ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension(CTEPH)."
داعم الدراسة
GSK
دواء الدراسة
Ambrisentan
رقم بروتوكول الدراسة
116457
حالة الدراسة
Terminated
موقع الدراسة
King Fahad Medical City (Riyadh)
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.